Ensign Peak Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.42M | Buy |
123,880
+29,265
| +31% | +$807K | 0.01% | 732 |
|
|
2025
Q1 | $2.68M | Buy |
94,615
+26,796
| +40% | +$760K | 0.01% | 804 |
|
|
2024
Q4 | $2.82M | Sell |
67,819
-770
| -1% | -$32K | 0.01% | 809 |
|
|
2024
Q3 | $4.58M | Sell |
68,589
-4,475
| -6% | -$299K | 0.01% | 648 |
|
|
2024
Q2 | $8.68M | Sell |
73,064
-80,198
| -52% | -$9.52M | 0.02% | 483 |
|
|
2024
Q1 | $16.3M | Buy |
153,262
+56,350
| +58% | +$6M | 0.03% | 359 |
|
|
2023
Q4 | $9.64M | Buy |
96,912
+14,735
| +18% | +$1.47M | 0.02% | 449 |
|
|
2023
Q3 | $8.49M | Buy |
82,177
+40,185
| +96% | +$4.15M | 0.02% | 432 |
|
|
2023
Q2 | $5.1M | Sell |
41,992
-107,060
| -72% | -$13M | 0.01% | 582 |
|
|
2023
Q1 | $22.9M | Buy |
149,052
+29,110
| +24% | +$4.47M | 0.05% | 265 |
|
|
2022
Q4 | $21.5M | Buy |
119,942
+63,368
| +112% | +$11.4M | 0.05% | 283 |
|
|
2022
Q3 | $6.69M | Sell |
56,574
-44,905
| -44% | -$5.31M | 0.02% | 459 |
|
|
2022
Q2 | $14.5M | Buy |
101,479
+4,870
| +5% | +$696K | 0.03% | 314 |
|
|
2022
Q1 | $16.6M | Buy |
96,609
+54,600
| +130% | +$9.41M | 0.03% | 324 |
|
|
2021
Q4 | $10.7M | Sell |
42,009
-37,848
| -47% | -$9.61M | 0.02% | 456 |
|
|
2021
Q3 | $30.7M | Buy |
79,857
+65,392
| +452% | +$25.2M | 0.06% | 240 |
|
|
2021
Q2 | $3.4M | Sell |
14,465
-13,845
| -49% | -$3.25M | 0.01% | 817 |
|
|
2021
Q1 | $3.71M | Sell |
28,310
-5,237
| -16% | -$686K | 0.01% | 764 |
|
|
2020
Q4 | $3.5M | Sell |
33,547
-42,148
| -56% | -$4.4M | 0.01% | 758 |
|
|
2020
Q3 | $5.36M | Buy |
75,695
+18,375
| +32% | +$1.3M | 0.01% | 612 |
|
|
2020
Q2 | $3.68M | Buy |
+57,320
| New | +$3.68M | 0.01% | 705 |
|